Application | Comment | Organism |
---|---|---|
medicine | DPP-4 inhibition augments postprandial lipid mobilization and oxidation and increases endogenous glucagon-like peptide 1 activity, resulting in improved glycemic control in patients with type 2 diabetes mellitus | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
vildagliptin | potent, selective DPP-4 inhibitor | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
glucagon-like peptide 1 + H2O | Homo sapiens | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
glucagon-like peptide 1 + H2O | - |
Homo sapiens | ? | - |
? | |
Gly-L-Pro-7-amido-4-methylcoumarin + H2O | - |
Homo sapiens | Gly-L-Pro + 7-amino-4-methylcoumarin | - |
? |
Synonyms | Comment | Organism |
---|---|---|
dipeptidyl peptidase-IV | - |
Homo sapiens |
DPP-4 | - |
Homo sapiens |